Literature DB >> 12700037

Membrane and synaptic effects of anti-S-100 are prevented by the same antibodies in low concentrations.

O I Epstein1, A Beregovoy, N S Sorokina, M V Starostina, M B Shtark, Kh L Gainutdinov, T Kh Gainutdinova, D I Muhamedshina.   

Abstract

Effects of antiserum to S-100 protein (AS-100) in high (HC, corresponding to antiserum dilution 1:5 - 1:50) and low (LC, 1:10(12)) concentrations were studied in identified snail neurons and rat hippocampal slices. HC-AS-100 changed the frequency of action potential generation in spontaneously active neurons and blocked formation of long-term potentiation in mossy fiber synapses. LC-AS-100 alone did not affect any characteristic measured in our experiments, but 20 min pre-incubation of snail ganglia or hippocampal slices with LC-AS-100 abolished the effects of the same antibodies in HC. Simultaneous addition of both LC and HC did not prevent the development of HC-AS-100 effects. It seems possible that LC-AS-100 is capable of interaction with neuronal cells modifying their reaction to HC-AS-100.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12700037     DOI: 10.2741/1025

Source DB:  PubMed          Journal:  Front Biosci        ISSN: 1093-4715


  3 in total

1.  Improvement of Memory by Means of Ultra-Low Doses of Antibodies to S-100B Antigen.

Authors:  O I Epstein; I F Pavlov; M B Shtark
Journal:  Evid Based Complement Alternat Med       Date:  2006-12       Impact factor: 2.629

2.  The randomized clinical trial results of the anxiety treatment in patients with somatoform dysfunction and neurotic disorders.

Authors:  Vladimir Anatolevich Parfenov; Pavel Rudolfovich Kamchatnov; Dina Rustemovna Khasanova; Enver Ibragimovich Bogdanov; Tatiana Markovna Lokshtanova; Aleksandr Vitalevich Amelin; Natalya Nikolaevna Maslova; Nataliia Vyacheslavovna Pizova; Galina Nikolaevna Belskaya; Evgeny Robertovich Barantsevich; Gulsum Abdurahmanovna Duchshanova; Saltanat Ualihanovna Kamenova; Oleg Vladimirovich Kolokolov; Alexey Borisovich Glazunov
Journal:  Sci Rep       Date:  2021-12-20       Impact factor: 4.996

3.  The novel oral drug Subetta exerts an antidiabetic effect in the diabetic Goto-Kakizaki rat: comparison with rosiglitazone.

Authors:  Danielle Bailbé; Erwann Philippe; Evgeniy Gorbunov; Sergey Tarasov; Oleg Epstein; Bernard Portha
Journal:  J Diabetes Res       Date:  2013-05-08       Impact factor: 4.011

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.